We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT01235221
Brief Title: Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials.

First Submitted : November 4, 2010
First Submitted that Met QC Criteria : November 4, 2010
First Posted : November 5, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : July 3, 2014
Last Update Posted : July 4, 2014 (Estimate)